Cholangiocarcinoma: New Insights to Pathogenesis & Treatment – CME Credit Information

Instructions to receive credit:

  1. View the presentation/review the information in this section.
    Cholangiocarcinoma: New Insights to Pathogenesis and Treatment – Alan Cubre, MD
  2. Once you have reviewed all of the educational content, click the “Claim CME” link, or navigate here. You will be directed to the Mass General Brigham Office of Professional Development Learning Management System.
  3. When prompted, log in using your Mass General Brigham credentials, or sign up as a visitor.
  4. Click the blue ‘Take Course’ button.
  5. Submit responses to the evaluation.
  6. Claim your credit.

Title: Cholangiocarcinoma: New Insights to Pathogenesis and Treatment
Release Date: September 7, 2022
Expiration Date: September 7, 2024
Description: Succinct, high-yield pre-recorded lecture by Dr. Alan Cubre
Faculty:

Course Directors:
Ramin Khorasani, MD, MPH
Vice Chair, Department of Radiology, Brigham and Women’s Hospital
Professor, Harvard Medical School

Sanjay Saini, MD
Vice Chairman for Finance, MGH Imaging, Abdominal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital
Professor of Radiology, Harvard Medical School

Speaker:
Alan Cubre, MD
Radiologist, Brigham & Women’s Hospital
Instructor, Harvard Medical School

Target Audience: This activity is intended for radiology attendings and trainees (fellows and residents) within Mass General Brigham.

Learning Objectives: Upon completion of the activity, participants will be able to accurately apply the most up to date Bosniak Classification System to the assessment of cystic renal masses with CT and MRI.

Accreditation Statement:
ACCREDITATION
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary of Relevant Financial Relationships:
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public. 

The following planners have reported no relevant financial relationship with an ineligible company:
Kristine S. Burk, MD
Ramin Khorasani, MD, MPH
Kathryn Nardozza
Sanjay Saini, MD

The following planners have reported a relevant financial relationship with an ineligible company:
Atul B. Shingare, MD
Consultant: Imaging Endpoints; Virtualscopics

The following speakers have reported no relevant financial relationships with an ineligible company:
Alan Cubre, MD

Scroll to Top